logo-loader
viewFacebook Inc

Facebook donating £4.5mln ($5.8mln) to train local journalists in the UK

Facebook said the two-year pilot - a global first for the platform - did not signal any move to start producing its own news content

Facebook F
The social media giant said it recognised the role it played in how people got their news and it wanted to do more to support local publishers

Facebook Inc. (NASDAQ:FB) is donating £4.5mln ($5.8mln) to train journalists in the UK to support communities that have lost local newspapers and reporters, according to media reports.

The social media giant said it recognised the role it played in how people got their news and it wanted to do more to support local publishers.

READ: Johnston Press bought by its bondholders after filing for bankruptcy protection on Friday

Around 80 new trainee reporters funded by Facebook will be recruited by regional publishers Newsquest, JPIMedia, Reach, Archant and the Midland News Association, in a scheme overseen by the National Council for the Training of Journalists (NCTJ), Reuters quoted Facebook as saying.

Facebook said the two-year pilot - a global first for the platform - did not signal any move to start producing its own news content.

On Friday, UK newspaper group Johnston Press PLC (LON:JPR) – publisher of the ‘I’ national newspaper as well as The Scotsman and The Yorkshire Post -  filed for administration and agreed to be bought by its bondholders after it concluded its equity had no value.

Newspaper groups have been struggling in the current environment in no little part due to news consumption switching online to Facebook.

Quick facts: Facebook Inc

Price: 192.47 USD

NASDAQ:FB
Market: NASDAQ
Market Cap: $548.63 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: TRACON Pharmaceuticals reveals its low-cost drug development...

TRACON Pharmaceuticals (NASDAQ:TCON) CEO Charles Theuer tells Proactive the biotechnology company ended 2019 with cash, cash equivalents and short-term investments of $16.4 million. Theuer explains despite engaging in five different clinical trials, three of the five company's clinical trials...

8 hours, 27 minutes ago

2 min read